Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

about

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed I

P2860

Q40063992-39DD1341-3C6A-4002-92C0-087481BDECA5

P2860

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

Item

http://www.wikidata.org/entity/Q40088776

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunogenicity and safety of 3 ...... HBV-IPV/Hib in Indian infants.

@en

type

Item

label

Immunogenicity and safety of 3 ...... HBV-IPV/Hib in Indian infants.

@en

prefLabel

Immunogenicity and safety of 3 ...... HBV-IPV/Hib in Indian infants.

@en

P1476

Immunogenicity and safety of 3 ...... HBV-IPV/Hib in Indian infants.

@en

P2093

Balasubramanian Sundaram

http://www.w3.org/2001/XMLSchema#string

Htay Htay Han

http://www.w3.org/2001/XMLSchema#string

Nandini Malshe

http://www.w3.org/2001/XMLSchema#string

Narcisa Mesaros

http://www.w3.org/2001/XMLSchema#string

Naveen Karkada

http://www.w3.org/2001/XMLSchema#string

Niranjana S Mahantashetti

http://www.w3.org/2001/XMLSchema#string

Olivier Van Der Meeren

http://www.w3.org/2001/XMLSchema#string

Sanjay K Lalwani

http://www.w3.org/2001/XMLSchema#string

Shailesh Mehta

http://www.w3.org/2001/XMLSchema#string

Shalaka Agarkhedkar

http://www.w3.org/2001/XMLSchema#string

P2860

Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life

Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.

A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.

Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Use of combination vaccines is associated with improved coverage rates.

Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome - Texas, 2013.

Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.

P304

120-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1225639

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27629913

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

5287296

http://www.w3.org/2001/XMLSchema#string

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

about

P2860

P2860

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932